
Join me for the 28th Southwest Prostate Cancer Symposium (#SPCS2025) in Las Vegas, NV on October 23-25, 2025! 🌟We will review new therapies for met PC: Lu-177 PSMA and beyond. grandroundsinurology.com/spc…
✓Director, Precision Medicine, Yale Cancer Center. Professor of Medicine, Yale School of Medicine. Chair, ACS National Prostate Cancer Roundtable. Views my own.

Join me for the 28th Southwest Prostate Cancer Symposium (#SPCS2025) in Las Vegas, NV on October 23-25, 2025! 🌟We will review new therapies for met PC: Lu-177 PSMA and beyond. grandroundsinurology.com/spc…

I hope we are able to implement these Guidelines to narrow persistent racial disparities in prostate cancer. (4) evidence.nejm.org/doi/full/1…

Today, @NEJMEvidence published our "PCF Screening Guidelines for Prostate Cancer in Black Men in the US," the work of a distinguished multidisciplinary panel that examined data and built consensus towards 6 clear guideline statements to positively impact this high risk group. (3)

I focused on 3 areas critical to blunt this trend: (1) early detection in high-risk individuals, (2) increased adoption of combination therapy in mHSPC and (3) use of RWE/AI to accelerate therapies in increasingly rare subtypes of prostate cancer. (2)

As I leave my role as CMO at Prostate Cancer Foundation, I am proud of the initiatives we launched to reduce death and suffering from this terrible and perplexing disease. The Lancet Commission projected doubling of global cases and 85% rise in prostate cancer deaths by 2040. (1)

@PCFnews Thought Leaders of the Future Program, August 10-12, Los Angeles👉Congrats and thanks to @charlesryanmd @WilliamOhMD @soulehoward1 @AndreaMiyahira and the PCF team for organizing this fantastic training/ mentoring event focusing on young investigators pursuing clinical/translational research in #prostatecancer 👉Excellent session#4 on various domains of research young faculty can pursue @CaPsurvivorship @EHeath4100 @KOSJ12 @loreleimucci @urotoday 👇

Thought Leaders of the Future Meeting #prostatecancer underway with some incredible leaders in GU Cancer Research 🤩Pathways to leadership and “keys to success” #prostatecancer @PCFnews @urotoday

William K. Oh, MD, and Charles J. Ryan, MD on Prostate Cancer Disparities and the ‘Last Mile’ Problem ascopost.com/issues/june-25-… #pcsm #prostatecancer #healthequity @IcahnMountSinai @charlesryanmd @PCFnews

We @PCFnews are proud to take this on, filling a much needed gap regarding screening + detection, treatment of localized disease, and treatment of advanced disease. Topics related to black men have been ignored in prior guidelines. @WilliamOhMD will convene the panel. More soon!

Is there a benefit to #LHRHantagonists (vs #agonists) in risk of #CV events in prostate cancer pts? This review suggests sparse evidence for a difference. Prob most important is make sure to have good CV evaluation prior to initiating any ADT. pubmed.ncbi.nlm.nih.gov/3586…

Platinum agents are active in mCRPC, but who responds? DDR mutations are relevant but are there other blood-based biomarkers? Funded by @PCFnews, this paper was a long time coming but is relevant in era of #NEPC and lethal #prostatecancer. @MountSinaiNYC academic.oup.com/oncolo/adva…

It was great to learn about all the progress that Dr Petereit and the team at Walking Forward have been making at addressing cancer disparities in #AmericanIndian health care. @AveraHealth @_monumenthealth @NCICRCHD @NCIDirector

A wonderful opportunity to have a leadership role at @MountSinaiNYC and @IcahnMountSinai as Director of Prostate Medical Oncology. Many outstanding GU colleagues and amazing clinical/scientific opportunities! #collaboration linkedin.com/jobs/view/33718…

Just in #ASCODailyNews @ASCO: Interview with @charlesryanmd CEO @PCFnews on the mission and vision of #ProstateCancerFoundation Congrats for building the next-gen investigators @soulehoward1 @AndreaMiyahira Take a listen👉https://t.co/csXvHjVQk5 @urotoday @OncoAlert @PCF_Science

I am incredibly excited to join you Chuck, @soulehoward1 and the whole @PCFnews team on this critical mission!
